{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T23:58:00Z","timestamp":1772927880946,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017959","name":"Health Commission of Hebei Province","doi-asserted-by":"publisher","award":["20231566"],"award-info":[{"award-number":["20231566"]}],"id":[{"id":"10.13039\/100017959","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003482","name":"Department of Education of Hebei Province","doi-asserted-by":"publisher","award":["BJK2023098"],"award-info":[{"award-number":["BJK2023098"]}],"id":[{"id":"10.13039\/501100003482","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.109017","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:23:47Z","timestamp":1758540227000},"page":"109017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Structure-guided design of a potent focal adhesion kinase (FAK) degrader via ternary complex modeling and molecular dynamics simulation"],"prefix":"10.1016","volume":"165","author":[{"given":"Chenxu","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaning","family":"Biao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109017_bb0005","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrc3792","article-title":"FAK in cancer: mechanistic findings and clinical applications","volume":"14","author":"Sulzmaier","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.109017_bb0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1242\/jcs.100115","article-title":"E-cadherin-integrin crosstalk in cancer invasion and metastasis","volume":"126","author":"Canel","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bioorg.2025.109017_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.109017_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2014.10.001","article-title":"FAK signaling in human cancer as a target for therapeutics","volume":"146","author":"Lee","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.109017_bb0025","article-title":"High expression of phosphorylated focal adhesion kinase predicts a poor prognosis in human colorectal cancer","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109017_bb0030","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3390\/biomedicines9121789","article-title":"FAK regulates VEGFR2 expression and promotes angiogenesis in triple-negative breast cancer","volume":"9","author":"Shiau","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2025.109017_bb0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jnci\/djx157","article-title":"Somatic mutations and splicing variants of focal adhesion kinase in non-small cell lung cancer","volume":"110","author":"Zhou","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioorg.2025.109017_bb0040","first-page":"4779","article-title":"Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer","volume":"17","author":"Nolasco-Quiroga","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bioorg.2025.109017_bb0045","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.3390\/ijms21165795","article-title":"Focal adhesion kinase (FAK) over-expression and prognostic implication in Pediatric hepatocellular carcinoma","volume":"21","author":"Francalanci","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109017_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100835","article-title":"Prognostic and clinical significance of focal adhesion kinase expression in breast cancer: a systematic review and meta-analysis","volume":"13","author":"Qiao","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bioorg.2025.109017_bb0055","doi-asserted-by":"crossref","first-page":"1274209","DOI":"10.3389\/fphar.2024.1274209","article-title":"Roles and inhibitors of FAK in cancer: current advances and future directions","volume":"15","author":"Hu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109017_bb0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41568-021-00340-6","article-title":"Targeting FAK in anticancer combination therapies","volume":"21","author":"Dawson","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.109017_bb0065","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s12276-020-0447-4","article-title":"Targeting focal adhesion kinase in cancer cells and the tumor microenvironment","volume":"52","author":"Murphy","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bioorg.2025.109017_bb0070","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1242\/jcs.045112","article-title":"Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions","volume":"123","author":"Schaller","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bioorg.2025.109017_bb0075","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nrm2996","article-title":"The FERM domain: organizing the structure and function of FAK","volume":"11","author":"Frame","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.109017_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004021","article-title":"Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics","volume":"6","author":"Cance","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bioorg.2025.109017_bb0085","doi-asserted-by":"crossref","first-page":"14382","DOI":"10.1021\/acs.jmedchem.0c01248","article-title":"Progress in the development of small molecular inhibitors of focal adhesion kinase (FAK)","volume":"63","author":"Lu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109017_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116246","article-title":"Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders","volume":"224","author":"Yang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109017_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116678","article-title":"Targeting focal adhesion kinase (FAK) in cancer therapy: a recent update on inhibitors and PROTAC degraders","volume":"276","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109017_bb0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109017_bb0105","doi-asserted-by":"crossref","first-page":"17019","DOI":"10.1021\/jacs.8b08008","article-title":"Addressing kinase-independent functions of Fak via PROTAC-mediated degradation","volume":"140","author":"Cromm","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.109017_bb0110","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/acs.jmedchem.8b01826","article-title":"Highly selective PTK2 proteolysis targeting chimeras to probe focal adhesion kinase scaffolding functions","volume":"62","author":"Popow","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109017_bb0115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s13238-020-00732-8","article-title":"FAK-targeting PROTAC as a chemical tool for the investigation of non-enzymatic FAK function in mice","volume":"11","author":"Gao","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.bioorg.2025.109017_bb0120","doi-asserted-by":"crossref","first-page":"23327","DOI":"10.1002\/anie.202109237","article-title":"Discovery and characterization of highly cooperative FAK-degrading PROTACs","volume":"60","author":"Law","year":"2021","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2025.109017_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114373","article-title":"Identification of novel and potent PROTACs targeting FAK for non-small cell lung cancer: design, synthesis, and biological study","volume":"237","author":"Sun","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109017_bb0130","article-title":"Development and characterization of selective FAK inhibitors and PROTACs with in vivo activity","volume":"24","author":"Koide","year":"2023","journal-title":"Chembiochem"},{"key":"10.1016\/j.bioorg.2025.109017_bb0135","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1021\/acs.jcim.0c01451","article-title":"Rationalizing PROTAC-mediated ternary complex formation using Rosetta","volume":"61","author":"Bai","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2025.109017_bb0140","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.apsb.2020.11.001","article-title":"Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo","volume":"11","author":"Luo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.109017_bb0145","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1021\/acs.jcim.8b00872","article-title":"In silico modeling of PROTAC-mediated ternary complexes: validation and application","volume":"59","author":"Drummond","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2025.109017_bb0150","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1021\/jacs.3c01852","article-title":"Small-molecule ferritin degrader as a pyroptosis inducer","volume":"145","author":"Chen","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.109017_bb0155","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1021\/acs.jmedchem.2c01864","article-title":"Catalytic degraders effectively address kinase site mutations in EML4-ALK oncogenic fusions","volume":"66","author":"Gao","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109017_bb0160","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1002\/anie.201901336","article-title":"Development of dual and selective degraders of cyclin-dependent kinases 4 and 6","volume":"58","author":"Jiang","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2025.109017_bb0165","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41589-021-00765-y","article-title":"Discovery and resistance mechanism of a selective CDK12 degrader","volume":"17","author":"Jiang","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.109017_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2023.03.007","article-title":"ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas","volume":"30","author":"Jiang","year":"2023","journal-title":"Cell Chem. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T20:33:08Z","timestamp":1760560388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":34,"alternative-id":["S0045206825008971"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109017","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided design of a potent focal adhesion kinase (FAK) degrader via ternary complex modeling and molecular dynamics simulation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109017"}}